Amarin Takes Vascepa Battle To Supreme Court
Suggests Hikma Launch Will Have Limited Impact; Dr Reddy’s Is Holding Off
Amarin has confirmed that it plans to take its legal battle over Vascepa all the way to the US Supreme Court, as it seeks to overturn a ruling that has already allowed Hikma to launch its generic rival.
